HU168890B - - Google Patents
Info
- Publication number
- HU168890B HU168890B HUAO351A HUAO000351A HU168890B HU 168890 B HU168890 B HU 168890B HU AO351 A HUAO351 A HU AO351A HU AO000351 A HUAO000351 A HU AO000351A HU 168890 B HU168890 B HU 168890B
- Authority
- HU
- Hungary
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/695—Corticotropin [ACTH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7202278A NL7202278A (enExample) | 1972-02-22 | 1972-02-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU168890B true HU168890B (enExample) | 1976-08-28 |
Family
ID=19815436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUAO351A HU168890B (enExample) | 1972-02-22 | 1973-02-20 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3853836A (enExample) |
| JP (1) | JPS4896586A (enExample) |
| AU (1) | AU471298B2 (enExample) |
| BE (1) | BE795788A (enExample) |
| CA (1) | CA1030953A (enExample) |
| CH (1) | CH585192A5 (enExample) |
| DE (1) | DE2308362A1 (enExample) |
| FR (1) | FR2181759B1 (enExample) |
| GB (1) | GB1416271A (enExample) |
| HU (1) | HU168890B (enExample) |
| NL (1) | NL7202278A (enExample) |
| ZA (1) | ZA73839B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7607684A (nl) * | 1976-07-12 | 1978-01-16 | Akzo Nv | Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan. |
| US4623715A (en) * | 1984-10-22 | 1986-11-18 | Hoechst Aktiengeselleschaft | Novel peptides which are active on the central nervous system and have an action on the cholinergic system |
| WO1986003746A1 (en) * | 1984-12-14 | 1986-07-03 | La Trobe University | Amino acid and peptide inhibitors of human leucocytic elastase |
| US5462927A (en) * | 1985-04-30 | 1995-10-31 | The Administrators Of The Tulane Educational Fund | Peptides aiding nerve regeneration |
| JP2525798B2 (ja) * | 1987-03-12 | 1996-08-21 | 第一製薬株式会社 | ペプチド誘導体 |
| WO1993000922A1 (en) * | 1991-07-01 | 1993-01-21 | The Administrators Of The Tulane Educational Fund | Peptides aiding nerve regeneration |
| US7176279B2 (en) * | 2000-06-28 | 2007-02-13 | Palatin Technologies, Inc. | Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| US6579968B1 (en) * | 1999-06-29 | 2003-06-17 | Palatin Technologies, Inc. | Compositions and methods for treatment of sexual dysfunction |
| DK1695703T3 (da) * | 2000-08-25 | 2010-10-25 | Res Corp Technologies Inc | Nye anvendelser for aminosyrekrampestillende midler |
| AU2002322466B2 (en) * | 2001-07-11 | 2007-08-30 | Palatin Technologies, Inc. | Linear and cyclic melanocortin receptor-specific peptides |
| US6974187B2 (en) * | 2004-01-28 | 2005-12-13 | Tachi-S Co., Ltd. | Vehicle seat structure |
| AU2005231034B2 (en) * | 2004-04-08 | 2010-04-08 | Telsar Pharma Inc. | Compound WS727713 |
| BRPI0508787A (pt) * | 2004-04-08 | 2007-09-04 | Astellas Pharma Inc | composto ws727713, cepa de actinomiceto, composto com atividade moduladora de receptor de melanocortina, processo para produzir o composto ws727713, modulador de receptor de melanocortina, uso do composto e composição farmacêutica |
| US20130059914A1 (en) | 2010-04-21 | 2013-03-07 | Signature Therapeutics, Inc. | Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof |
| US11590209B2 (en) | 2020-01-21 | 2023-02-28 | Palatin Technologies, Inc. | Use of bremelanotide in patients with controlled hypertension |
| CA3199184A1 (en) * | 2020-11-18 | 2022-05-27 | Felix Lustenberger | Mdma prodrugs to assist psychotherapy |
| US12384744B2 (en) | 2021-09-29 | 2025-08-12 | Ensysce Biosciences Inc. | Enzyme-cleavable methadone prodrugs and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1302396A (fr) * | 1961-03-10 | 1962-08-31 | Ciba Geigy | Procédés de préparation de nouveaux heptapeptides de formule l-alpha-[mercaptoalcoyl (inférieur)]-alpha-amino-acétyl-l-glutaminyl-l-histidyl-l-phényl alanyl-l-alpha-[amino-alcoyl (inférieur)]-alpha-amino-acétyl-l-tryptophyl glycine |
| NL278010A (enExample) * | 1961-05-04 | 1900-01-01 | ||
| NL6509727A (enExample) * | 1965-07-28 | 1967-01-30 | ||
| GB1230472A (enExample) * | 1967-07-10 | 1971-05-05 |
-
0
- BE BE795788D patent/BE795788A/xx unknown
-
1972
- 1972-02-22 NL NL7202278A patent/NL7202278A/xx unknown
-
1973
- 1973-02-06 ZA ZA730839A patent/ZA73839B/xx unknown
- 1973-02-08 AU AU51979/73A patent/AU471298B2/en not_active Expired
- 1973-02-08 GB GB621973A patent/GB1416271A/en not_active Expired
- 1973-02-12 US US00331945A patent/US3853836A/en not_active Expired - Lifetime
- 1973-02-20 HU HUAO351A patent/HU168890B/hu unknown
- 1973-02-20 DE DE19732308362 patent/DE2308362A1/de active Pending
- 1973-02-21 CH CH245873A patent/CH585192A5/xx not_active IP Right Cessation
- 1973-02-21 JP JP48021120A patent/JPS4896586A/ja active Pending
- 1973-02-21 CA CA164,274A patent/CA1030953A/en not_active Expired
- 1973-02-22 FR FR7306338A patent/FR2181759B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2181759B1 (enExample) | 1976-09-03 |
| GB1416271A (en) | 1975-12-03 |
| CH585192A5 (enExample) | 1977-02-28 |
| ZA73839B (en) | 1973-11-28 |
| US3853836A (en) | 1974-12-10 |
| NL7202278A (enExample) | 1973-08-24 |
| CA1030953A (en) | 1978-05-09 |
| JPS4896586A (enExample) | 1973-12-10 |
| FR2181759A1 (enExample) | 1973-12-07 |
| AU5197973A (en) | 1974-08-08 |
| DE2308362A1 (de) | 1973-09-06 |
| AU471298B2 (en) | 1976-04-15 |
| BE795788A (nl) | 1973-08-22 |